Gillian Reyes-Marcelino
Biographic Data
| ID | 7801747 |
|---|---|
| NAME | Gillian Reyes-Marcelino |
| GIVEN NAMES | Gillian |
| FAMILY NAME | Reyes-Marcelino |
| SIGNATURE | REYES-MARCELINO G |
| AFFILIATIONS | The University of Sydney |
| ORCID | 0000-0002-3250-0961 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
‘There is a lot of good in knowing, but there is also a lot of downs’
Publics are key stakeholders in population genomic screening and their perspectives on ethical considerations are relevant to programme design and policy making. Using semi-structured interviews, we explored social views and attitudes towards possible future provision of personalised genomic risk information to populations to inform prevention and/or early detection of relevant conditions. Participants were members of the public (n=30) who had re…
Implementation considerations for offering personal genomic risk information to the public
Participants felt that offering personal genomic risk information to the general population to inform prevention and early detection recommendations is acceptable, particularly for common, complex conditions such as cancer. Understanding participants' preferences for receiving genomic risk information will assist with communication strategies and health workforce planning. We anticipate that these findings will contribute to the development of im…
No prominent works on this page.
Implementation considerations for offering personal genomic risk information to the public
Participants felt that offering personal genomic risk information to the general population to inform prevention and early detection recommendations is acceptable, particularly for common, complex conditions such as cancer. Understanding participants' preferences for receiving genomic risk information will assist with communication strategies and health workforce planning. We anticipate that these findings will contribute to the development of im…
‘There is a lot of good in knowing, but there is also a lot of downs’
Publics are key stakeholders in population genomic screening and their perspectives on ethical considerations are relevant to programme design and policy making. Using semi-structured interviews, we explored social views and attitudes towards possible future provision of personalised genomic risk information to populations to inform prevention and/or early detection of relevant conditions. Participants were members of the public (n=30) who had re…
BRCA gene mutations in cancer (2 works) · Ethics in Clinical Research (2 works) · Medicine (2 works) · Nursing (2 works) · Population (2 works) · Public health (2 works) · Biology (1 work) · Biostatistics (1 work) · Environmental health (1 work) · Genetic testing (1 work)